Covers the effects of norepinephrine, cholinergic and adrenergic receptors, sympathomimetics, cholinesterase inhibitors, and clinical uses of sympathomimetics.
Explores motor neuron diseases, discussing their classification, pathological signatures, etiology, and potential treatments, with a focus on Spinal Muscular Atrophy.
